Cynthia W. Hu Net Worth

The estimated Net Worth of Cynthia W. Hu is at least $248 mil dollars as of 14 January 2019. Cynthia Hu owns over 15,000 units of CASI Pharmaceuticals Inc stock worth over $247,527 and over the last 10 years Cynthia sold CASI stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Cynthia Hu CASI stock SEC Form 4 insiders trading

Cynthia has made over 2 trades of the CASI Pharmaceuticals Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Cynthia exercised 15,000 units of CASI stock worth $26,400 on 14 January 2019.

The largest trade Cynthia's ever made was buying 16,800 units of CASI Pharmaceuticals Inc stock on 19 January 2016 worth over $12,096. On average, Cynthia trades about 2,650 units every 91 days since 2014. As of 14 January 2019 Cynthia still owns at least 32,785 units of CASI Pharmaceuticals Inc stock.

You can see the complete history of Cynthia Hu stock trades at the bottom of the page.

What's Cynthia Hu's mailing address?

Cynthia's mailing address filed with the SEC is CASI PHARMACEUTICALS, INC., 9620 MEDICAL CENTER DRIVE, SUITE 300, ROCKVILLE, MD, 20850.

Insiders trading at CASI Pharmaceuticals Inc

Over the last 12 years, insiders at CASI Pharmaceuticals Inc have traded over $0 worth of CASI Pharmaceuticals Inc stock and bought 30,834,178 units worth $51,898,666 . The most active insiders traders include Wei Wu He, Rajesh C Md Shrotriya, ePharmaceuticals Inc Spectru.... On average, CASI Pharmaceuticals Inc executives and independent directors trade stock every 91 days with the average trade being worth of $6,141,555. The most recent stock trade was executed by James Huang on 6 September 2022, trading 55,573 units of CASI stock currently worth $229,516.

What does CASI Pharmaceuticals Inc do?

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market leveraging the Company’s China-based regulatory and commercial competencies and its global drug development expertise. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China.

Complete history of Cynthia Hu stock trades at CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc executives and stock owners

CASI Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Wei-Wu He,
  Executive Chairman of the Board, Chief Executive Officer
• Alexander Zukiwski,
  Chief Medical Officer
• Wei Zhang,
  President, President of CASI China, Interim Principal Financial Officer
• Dr. Wei-Wu He Ph.D.,
  Chairman & CEO
• Dr. Wei Zhang Ph.D.,
  Pres & Principal Financial Officer
• Dr. Alexander A. Zukiwski M.D.,
  Exec. VP & Chief Medical Officer
• James Huang,
  Independent Director
• Y. Alexander Wu,
  Independent Director
• Franklin Salisbury,
  Independent Director
• Quan Zhou,
  Independent Director
• Rajesh Shrotriya,
  Independent Director
• Amanda Cui,
  VP & Global Controller
• Dr. James E. Goldschmidt Ph.D.,
  Chief Bus. Devel. Officer
• Sara B. Capitelli CPA,
  VP of Fin.
• Byte Ltdsnow Moon Ltdtianji...,
  
• Ken Ren,
  CEO and Director
• Pharmaceuticals Inc Spectru...,
  
• Alex Wu,
  Director
• Tak W. Mak,
  Director
• China Growth Fund Iii L.P.I...,
  
• Strategy Holding Ltd Wealth,
  10% owner
• Sara B Capitelli,
  VP, Finance & PAO
• George Chi,
  Chief Financial Officer
• Cynthia W. Hu,
  See Remarks
• Byte Ltdsnow Moon Ltdtianji...,
  
• Ken Keyong Ren,
  Chief Executive Officer
• Larry Zhang,
  President
• Weihao Xu,
  Chief Financial Officer